Given that TREM2+ cells exist in SCCs (which have enhanced levels of LY6D), we would predict distinct differentiation paths and effector functions of TREM2+ cells between these two tumor types, likely driven by critical differences in the TME and tumor epithelium40. The gene discussed is TREM2; the disease is neoplasm.